The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Trending
- Robert Suarez could be an X factor for Braves headed into postseason
- Why Astros’ Yordan Alvarez should win AL MVP
- ‘Million Dollar Secret’ Casts West Wilson & Brianna Chickenfry Amid Drama
- Taylor & Tay Lautner Reveal Their Daughter’s Name & Yes, They Did The Thing
- Meet Phoenix Giselle, The Youngest Female Yoga Instructor
- Why IFBB Pro Bodybuilder Sheriff Taiwo Uses Walking to Help Lose Fat
- Under 100 days left to enter the Business Champion Awards
- Tuberville torn apart for claim Alabama voters can ‘deal’ with high costs
